16 January 2020

In Paediatric and Perinatal Epidemiology Marleen van Gelder and Nel Roeleveld described the recruitment methods and online data collection within the PRIDE Study, the largest Dutch birth cohort study and among the firsts to use Web-based questionnaires as mode of data collection in medical research.
 
The PRegnancy and Infant DEvelopment (PRIDE) Study is an ongoing prospective cohort study among pregnant women. Its primary aim is to identify exposures during pregnancy and in early life that may affect short‐term or long‐term health of mother and/or child. Dutch women are invited for participation as early in pregnancy as possible (mean gestational week: 10). Initially, only prenatal care providers recruited participants, but alternative recruitment methods were added, including collaboration with ‘Moeders voor Moeders’ and social media advertisements. Characteristics of participants differ between recruitment methods. Although recruitment rates were lower than expected based on the pilot study, we expect to include the 10,000th pregnancy by the end of January, making the PRIDE Study the largest birth cohort study in the Netherlands.
 
Priority exposures include medication use during pregnancy, maternal depressive symptoms, physical and emotional stress, occupational exposures, and lifestyle factors, whereas pregnancy complications, birth outcomes, childhood asthma, and ADHD are among the priority outcomes. We were among the firsts to implement Web-based questionnaires as a method of data collection in medical research. Our studies showed that the validity of data collected through Web-based questionnaires was similar or even higher compared to traditional methods of data collection in similar settings. In addition to the prenatal (baseline, gestational weeks 17 and 34) and biannual post-partum questionnaires, we collect data with paternal questionnaires, food frequency questionnaires, and blood and saliva samples among subgroups. Furthermore, various focus cohorts are implemented for dedicated data collection.
 
Lessons learned include the acceptance of technical hassles, the need for additional efforts to reduce loss to follow-up, and the strong preference of the study population for administration of questionnaires on smartphones, which needs additional programming. The PRIDE Study is open for collaboration.
 
Publication
The PRIDE Study: Evaluation of online methods of data collection
van Gelder MMHJ, Merkus PJFM, van Drongelen J, Swarts JW, van de Belt TH, Roeleveld N.
 

Related news items


Large AI project receives over €95 million for ten years of public-private research

23 September 2021

The Dutch Research Council (NWO) is to fund two consortia for a period of ten years. Radboudumc participates in the ROBUST consortium, which consists of 17 AI labs, eight of which are dedicated to healthcare. Radboudumc leads five of these eight labs.

read more

Reading ADP-ribosylation signaling using chemical biology and interaction proteomics published in Molecular Cell

22 September 2021

Kasia Kliza and Michiel Vermeulen worked on a project to synthesize biotinylated ADPr-based probes that can identify ADPr readers and determine their specificity for mono- and polyADPr. They published this in Molecular Cell.

read more

Systematic analysis of short tandem repeats in 38,095 exomes provides an additional diagnostic yield

22 September 2021

Christian Gilissen and colleagues published in Genetics in Medicine about their work guiding the application of short tandem repeat analysis in clinical exome sequencing.

read more

TropIQ seeks new mosquito repellents

21 September 2021

TropIQ Health Sciences, a Radboudumc spin-off, has received a 1.3 million USD grant from the Bill & Melinda Gates Foundation to track down new mosquito repellents.

read more

New start-up Patholyt will bring AI research into pathology diagnostics

21 September 2021

Patholyt is on a mission to accelerate the adoption of artificial intelligence in pathology diagnostics and improve the chances of cancer patients worldwide. Patholyt is a spin-off from Radboudumc, a frontrunner in computational pathology research.

read more

Treatment of most common skin cancer can sometimes wait

20 September 2021

Not treating but keeping an eye on the cancer is also an option

read more